DALLAS — ProPath, which specializes in anatomic pathology and clinical testing, announces a national contract with Humana Inc., one of the nation’s leading health and well-being companies, effective Feb. 1, 2019.

ProPath’s team of board-certified pathologists comprises subspecialty-trained experts in 20 different areas including dermatopathology, women’s health, gastrointestinal pathology, hematopathology, immunohistochemistry, podiatric pathology, renal pathology,  breast pathology,  urologic pathology and molecular diagnostics. They will provide a wide array of services to physicians and other health care providers contracted with Humana and Humana commercial and Medicare members.

“ProPath has provided medical diagnostics to Humana members in Texas and nationally under the ChoiceCare PPO agreement for more than 16 years and we are proud to expand to all Humana products through a national contract,” said ProPath President and Chief Executive Officer Cory A. Roberts, M.D. “Our agreement allows Humana’s commercial and Medicare members across the U.S. access to ProPath’s premier highly specialized, diagnostic medical care team.”

“In keeping with our commitment to help millions of medical and specialty members achieve their best health, Humana has expanded our relationship with ProPath and its board-certified pathology experts,” said George Renaudin, Senior Vice President at Humana. “The expanded agreement means more of our Humana members and contracted providers will have access to specialized testing that will lead to better access to care.”

To learn more about ProPath, visit www.propath.com.

 

About ProPath

ProPath, based in Dallas, is the premier provider of pathology services to clinicians and medical facilities nationwide. As a physician-owned organization founded in 1966, ProPath is devoted to comprehensive, high-quality anatomic and clinical laboratory testing for unparalleled patient care. ProPath’s team of board-certified physicians offers subspecialty expertise and training in 20 areas. Advanced technologies and highly trained staff allow for accuracy and efficiency in research, diagnosis and information delivery. Specimens are processed and interpretations/ diagnoses are delivered to referring clinicians within 24 hours.

 

About Humana Inc.

Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information

Additional Information

Humana is a Medicare Advantage HMO and PPO organization with a Medicare contract. Enrollment in any Humana plan depends on contract renewal. Other providers are available in our network. Call 1-877-877-0714 (TTY: 711) 8 a.m. to 8 p.m. local time seven days a week.

 

-30-

Contact:

Douglas Kale

ProPath

Marketing Manager

214-237-1658

[email protected]